Peripheral artery disease is a condition of the blood vessels that leads to narrowing and hardening of the arteries that supply the legs and feet. Treatment options include regular exercise, improved diet and medication prescribed by a physician. For some patients, these treatments are not enough and minimally invasive treatment or surgery may be needed. Surgical options include peripheral artery bypass surgery of the leg or angioplasty and stent placement in the peripheral arteries of the affected extremity.

"We are pleased to begin this trial of our FUSION peripheral grafts as we believe they represent an innovative advancement in vascular grafts. We believe that the addition of the BIOLINE coating to the unique FUSION hybrid construction will set a new standard for peripheral bypass treatment," said Bodo Anders, President of MAQUET Cardiovascular's Vascular Interventions Business Unit.

The investigational FUSION Vascular Grafts are synthetic vascular grafts constructed of two layers “ an inner layer comprised of extruded, expanded polytetrafluoroethylene (ePTFE) and a PET knit polyester textile outer layer. These two layers are fused together with a proprietary polycarbonate-urethane adhesive.  

The investigational FUSION BIOLINE Vascular Graft is coated on the luminal service with recombinant albumin and heparin.

SOURCE MAQUET Cardiovascular LLC